Intravenous administration of heterodimeric phospholipase A2 HDP-1 disturbs cardiovascular system functions and biochemical composition of blood in anesthesiated rats
- 作者: Ismailova A.M.1, Severyukhina M.S.1,2, Shaykhutdinova E.R.1, Perepechenova N.A.1, Starkov V.G.1, Dyachenko I.A.1,2, Tsetlin V.I.1, Utkin Y.N.1
-
隶属关系:
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences
- the Federal State Budgetary Educational Institution of Higher Education “Russian Biotechnological University (ROSBIOTECH)”
- 期: 卷 522, 编号 1 (2025)
- 页面: 317-323
- 栏目: Articles
- URL: https://vestnik.nvsu.ru/2686-7389/article/view/686334
- DOI: https://doi.org/10.31857/S2686738925030019
- ID: 686334
如何引用文章
详细
Heterodimeric phospholipase A2 HDP-1 from the venom of Nikolsky viper consists of two non-covalently bound subunits – HDP-1P and HDP-1In, the first of which exhibits lipolytic activity, while the second does not. The subunits have close molecular masses and similar amino acid sequences. Administration of HDP-1 and HDP-1P to anesthetized rats is accompanied by prolonged hypotensive effects, the intensity of which depends on the dose. With the administration of HDP-1P, the effect develops more slowly than in the case of HDP-1 containing both subunits, while individual HDP-1In does not affect hemodynamic parameters. It was found using electrocardiography that HDP-1 and HDP-1P affect the functioning of the rat heart, causing arrhythmia, which may indicate their ability to affect the innervation of the heart. The administration of HDP-1 and its subunits also leads to changes in biochemical blood parameters, indicating their damaging effect on cells and internal organs.
全文:

作者简介
A. Ismailova
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences
Email: utkin@ibch.ru
Branch
俄罗斯联邦, Moscow; PushcinoM. Severyukhina
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences; the Federal State Budgetary Educational Institution of Higher Education “Russian Biotechnological University (ROSBIOTECH)”
Email: utkin@ibch.ru
Branch, Pushchino branch
俄罗斯联邦, Moscow; Pushchino; PuschinoE. Shaykhutdinova
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences
Email: utkin@ibch.ru
Branch
俄罗斯联邦, Moscow; PushcinoN. Perepechenova
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences
Email: utkin@ibch.ru
Branch
俄罗斯联邦, PushchinoV. Starkov
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences
Email: utkin@ibch.ru
俄罗斯联邦, Moscow
I. Dyachenko
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences; the Federal State Budgetary Educational Institution of Higher Education “Russian Biotechnological University (ROSBIOTECH)”
Email: utkin@ibch.ru
Branch, Pushchino branch
俄罗斯联邦, Moscow; Pushchino; PushchinoV. Tsetlin
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences
Email: utkin@ibch.ru
Corresponding Member of the RAS
俄罗斯联邦, MoscowYu. Utkin
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences
编辑信件的主要联系方式.
Email: utkin@ibch.ru
俄罗斯联邦, Moscow
参考
- Филькин C.Ю., Липкин А.В., Федоров А.Н. Суперсемейство фосфолипаз: структура, функции и применение в биотехнологии // Успехи биологической химии. 2020. Т. 60. С. 369–410.
- Dennis E.A., Cao J., Hsu Y.-H., et al. Phospholipase A2 Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention // Chemical Reviews. 2011. V. 111. №10. P. 6130–6185.
- Schiavo G., Matteoli M., Montecucco C. Neurotoxins affecting neuroexocytosis // Pysiol. Rev. 2000. V. 80. P. 717–766.
- Chaisakul J., Isbister G.K., Tare M., et al. Hypotensive and vascular relaxant effects of phospholipase A2 toxins from Papuan taipan (Oxyuranus scutellatus) venom // Eur. J. Pharmacol. 2014. V. 723. P. 227–233.
- Silveira L.B., Marchi-Salvador D.P., Santos-Filho N.A., et al. Isolation and expression of a hypotensive and anti-platelet acidic phospholipase A2 from Bothrops moojeni snake venom // J. Pharm. Biomed. Anal. 2013. V. 73. P. 35–43.
- Ramazanova A.S., Zavada L.L., Starkov V.G., et al. Heterodimeric neurotoxic phospholipases A2-the first proteins from venom of recently established species Vipera nikolskii: implication of venom composition in viper systematics // Toxicon. 2008. Vol. 5. №4. P. 524–537.
- Animal Clinical Chemistry: A Practical Handbook for Toxicologists and Biomedical Researchers, Second Edition / Edited By G.O. Evans. Published April 8, 2009 by CRC Press. 366 р.
- Averin A., Starkov V., Tsetlin V., et al. Effects of the Heterodimeric Neurotoxic Phospholipase A2 from the Venom of Vipera nikolskii on the Contractility of Rat Papillary Muscles and Thoracic Aortas // Toxins (Basel). 2024. V. 16. №2. P. 100.
- Cicala C., Cirino G. Phospholipase A2-induced hypotension in the rat and its pharmacological modulation // Gen. Pharmacol. 1993. Vol. 24. №5. P. 1197–1202.
- Peterfi O., Boda F., Szabo Z., et al. Hypotensive Snake Venom Components-A Mini-Review // Molecules. 2019. Vol. 24. №15. P. 2778.
- Frangieh J., Rima M., Fajloun Z., et al. Snake Venom Components: Tools and Cures to Target Cardiovascular Diseases // Molecules. 2021. Vol. 26. №8. P. 2223.
- Sartim M.A., Nogueira R.C., Cavalcante T.T.A., et al. Hemodynamic impairment induced by Crotoxin using in vivo and ex vivo approach in a rat model // Int. J. Biol. Macromol. 2023. V. 232. P. 123408.
- Akine A., Suzuka H., Hayashida Y., et al. Effects of ketamine and propofol on autonomic cardiovascular function in chronically instrumented rats // Auton. Neurosci. 2001. V. 87. №2-3. P. 201–208.
补充文件
